341 related articles for article (PubMed ID: 32312681)
21. Targeted therapy of human leukemia xenografts in immunodeficient zebrafish.
Somasagara RR; Huang X; Xu C; Haider J; Serody JS; Armistead PM; Leung T
Sci Rep; 2021 Mar; 11(1):5715. PubMed ID: 33707624
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.
Friedman AA; Xia Y; Trippa L; Le LP; Igras V; Frederick DT; Wargo JA; Tanabe KK; Lawrence DP; Neuberg DS; Flaherty KT; Fisher DE
Clin Cancer Res; 2017 Aug; 23(16):4680-4692. PubMed ID: 28446504
[No Abstract] [Full Text] [Related]
23. Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening.
Costa B; Estrada MF; Barroso MT; Fior R
Curr Protoc; 2022 Apr; 2(4):e415. PubMed ID: 35436037
[TBL] [Abstract][Full Text] [Related]
24. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
25. Patient-derived xenograft models for personalized medicine in colorectal cancer.
Xie J; Lin Y
Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
[TBL] [Abstract][Full Text] [Related]
26. Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform.
Xing F; Liu YC; Huang S; Lyu X; Su SM; Chan UI; Wu PC; Yan Y; Ai N; Li J; Zhao M; Rajendran BK; Liu J; Shao F; Sun H; Choi TK; Zhu W; Luo G; Liu S; Xu L; Chan KL; Zhao Q; Miao K; Luo KQ; Ge W; Xu X; Wang G; Liu TM; Deng CX
Theranostics; 2021; 11(19):9415-9430. PubMed ID: 34646378
[TBL] [Abstract][Full Text] [Related]
27. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
28. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
29. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.
Powley IR; Patel M; Miles G; Pringle H; Howells L; Thomas A; Kettleborough C; Bryans J; Hammonds T; MacFarlane M; Pritchard C
Br J Cancer; 2020 Mar; 122(6):735-744. PubMed ID: 31894140
[TBL] [Abstract][Full Text] [Related]
30. Using zebrafish models of leukemia to streamline drug screening and discovery.
Deveau AP; Bentley VL; Berman JN
Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
[TBL] [Abstract][Full Text] [Related]
31. Zebrafish xenografts as a tool for in vivo studies on human cancer.
Konantz M; Balci TB; Hartwig UF; Dellaire G; André MC; Berman JN; Lengerke C
Ann N Y Acad Sci; 2012 Aug; 1266():124-37. PubMed ID: 22901264
[TBL] [Abstract][Full Text] [Related]
32. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
Gerhards NM; Rottenberg S
Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
[TBL] [Abstract][Full Text] [Related]
33. Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool.
Cabezas-Sainz P; Guerra-Varela J; Carreira MJ; Mariscal J; Roel M; Rubiolo JA; Sciara AA; Abal M; Botana LM; López R; Sánchez L
BMC Cancer; 2018 Jan; 18(1):3. PubMed ID: 29291719
[TBL] [Abstract][Full Text] [Related]
34. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
[TBL] [Abstract][Full Text] [Related]
35. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS
Cancer Biol Ther; 2018; 19(12):1078-1087. PubMed ID: 30299205
[TBL] [Abstract][Full Text] [Related]
36. Zebrafish: Speeding Up the Cancer Drug Discovery Process.
Letrado P; de Miguel I; Lamberto I; Díez-Martínez R; Oyarzabal J
Cancer Res; 2018 Nov; 78(21):6048-6058. PubMed ID: 30327381
[TBL] [Abstract][Full Text] [Related]
37. Patient-derived xenografts as in vivo models for research in urological malignancies.
Inoue T; Terada N; Kobayashi T; Ogawa O
Nat Rev Urol; 2017 May; 14(5):267-283. PubMed ID: 28248952
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of transcriptome in cancer patient-derived xenografts.
Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
[TBL] [Abstract][Full Text] [Related]
39. Personalized
Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
[TBL] [Abstract][Full Text] [Related]
40. Prioritizing therapeutic targets using patient-derived xenograft models.
Lodhia KA; Hadley AM; Haluska P; Scott CL
Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
